PINETREE THERAPEUTICS

Live / Registered — Registered (as of 31 Dec 2024)

What this means for you

Registered since 31 Dec 2024. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
90534257
Registration number
7634072
Mark type
Stylized text
Filed
18 Feb 2021
Published for opposition
28 Jun 2022
Registered
31 Dec 2024
Attorney of record
Kongsik Kim

Goods and services

  • Class 042 — Scientific and technological services: Research and development of pharmaceuticals for others; Research and development of pharmaceuticals for others related to cancer, infectious diseases, and viral related diseases and disorders; Medical research; Medical laboratories; Medical and scientific research in the field of cancer, infectious diseases, and viral related diseases and disorders; Clinical research in the field of cancer, infectious diseases, and viral related diseases and disorders; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Compiling data for research purposes in the field of medical science and medical consultancy
  • Class 044 — Medical, beauty and agricultural services: medical informational services, namely, providing health information in the field of cancer, infectious diseases, and viral related diseases and disorders via a global computer network; Providing medical information; Providing health information; Providing medical and health information related to cancer, infectious diseases, and viral related diseases and disorders; Medical consulting services in the field of cancer, infectious diseases, and viral related diseases and disorders

Owner

Prosecution history

  • 31 Dec 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 31 Dec 2024 — REGISTERED-PRINCIPAL REGISTER
  • 27 Oct 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 27 Oct 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 26 Oct 2024 — STATEMENT OF USE PROCESSING COMPLETE
  • 22 Aug 2024 — USE AMENDMENT FILED
  • 26 Oct 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 22 Aug 2024 — TEAS STATEMENT OF USE RECEIVED
  • 24 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 23 Feb 2024 — SOU EXTENSION 3 GRANTED
  • 23 Feb 2024 — SOU EXTENSION 3 FILED
  • 23 Feb 2024 — SOU TEAS EXTENSION RECEIVED
  • 25 Aug 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 23 Aug 2023 — SOU EXTENSION 2 GRANTED
  • 23 Aug 2023 — SOU EXTENSION 2 FILED

View this trademark record on Marksy